Invest in SPARK Microgravity: Building the Orbital Cancer Lab

SPARK Microgravity is a Munich-based space-biotech startup building the first autonomous orbital laboratory for cancer research. Our technology generates more predictive biological data for pharmaceutical R&D — helping accelerate oncology drug discovery and personalized medicine.

Following a successful early financing phase, we are now expanding our partnerships and preparing for the next growth stage. SPARK is open to conversations with investors who share our vision to make space biology commercially scalable and scientifically impactful.

Focus areas:

• Hardware and data infrastructure for microgravity life-science missions

• Translational oncology research and pharma collaboration

• Long-term platform development across orbital and sub-orbital environments

We’re building a bridge between biotechnology and space, turning orbital research into a practical tool for the life-science industry.